Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

In order to isolate the precursor from blood, we synthesized an affinity sorbent with cross-linked 25-hydroxy vitamin D3 and developed a chromatography procedure that differed completely from the method described previously in ref. [35]. 25-OH-D3/Sepharose® turned out to be a stable substrate enabling up to nine chromatography runs and even more per portion of resin.

Source: 3.1. Differences in DBPs Isolated Using the Actin/chitin and 25-OH-D3/Sepharose® Affinity Sorbents, Tandem Mass Spectrometry Analysis of the Two Fractions Isolated Using 25-OH-D3/Sepharose®. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Mixed research settings

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Therefore, the model for assessing the synthesis of pro-inflammatory mediators TNF-α and IL-1β and the major anti-inflammatory cytokines TGF-β and IL-10 by peritoneal macrophages isolated from C57BL/6 mice was chosen to analyze the activating ability of DBP and GcMAF.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

The Molecular Aspects of Functional Activity of Macrophage-Activating Factor GcMAF

Study design awaiting verification · International Journal of Molecular Sciences · 2023

Original publication title

The Molecular Aspects of Functional Activity of Macrophage-Activating Factor GcMAF

Svetlana S. Kirikovich; Evgeniy V. Levites; Anastasia S. Proskurina; Genrikh S. Ritter; Sergey E. Peltek; Asya R. Vasilieva; Vera S. Ruzanova; Evgeniya V. Dolgova; Sofya G. Oshihmina; Alexandr V. Sysoev; Danil I. Koleno; Elena D. Danilenko; Oleg S. Taranov; Alexandr A. Ostanin; Elena R. Chernykh; Nikolay A. Kolchanov; Sergey S. Bogachev

© 2023 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Group-specific component macrophage-activating factor (GcMAF) is the vitamin D3-binding protein (DBP) deglycosylated at Thr420. The protein is believed to exhibit a wide range of therapeutic properties associated with the activation of macrophagal immunity. An original method for GcMAF production, DBP conversion to GcMAF, and the analysis of the activating potency of GcMAF was developed in this study. Data unveiling the molecular causes of macrophage activation were obtained. GcMAF was found to interact with three CLEC10A derivatives having molecular weights of 29 kDa, 63 kDa, and 65 kDa.

GcMAF interacts with high-molecular-weight derivatives via Ca2+-dependent receptor engagement. Binding to the 65 kDa or 63 kDa derivative determines the pro: and anti-inflammatory direction of cytokine mRNA expression: 65 kDa: pro-inflammatory (TNF-α, IL-1β) and 63 kDa: anti-inflammatory (TGF-β, IL-10). No Ca2+ ions are required for the interaction with the canonical 29 kDa CLEC10A. Both forms, DBP protein and GcMAF, bind to the 29 kDa CLEC10A. This interaction is characterized by the stochastic mRNA synthesis of the analyzed cytokines. Ex vivo experiments have demonstrated that when there is an excess of GcMAF ligand, CLEC10A forms aggregate, and the mRNA synthesis of analyzed cytokines is inhibited.

A schematic diagram of the presumable mechanism of interaction between the CLEC10A derivatives and GcMAF is provided. The principles and elements of standardizing the GcMAF preparation are elaborated.

Authors’ abstract

Group-specific component macrophage-activating factor (GcMAF) is the vitamin D3-binding protein (DBP) deglycosylated at Thr420. The protein is believed to exhibit a wide range of therapeutic properties associated with the activation of macrophagal immunity. An original method for GcMAF production, DBP conversion to GcMAF, and the analysis of the activating potency of GcMAF was developed in this study. Data unveiling the molecular causes of macrophage activation were obtained. GcMAF was found to interact with three CLEC10A derivatives having molecular weights of 29 kDa, 63 kDa, and 65 kDa.

GcMAF interacts with high-molecular-weight derivatives via Ca2+-dependent receptor engagement. Binding to the 65 kDa or 63 kDa derivative determines the pro: and anti-inflammatory direction of cytokine mRNA expression: 65 kDa: pro-inflammatory (TNF-α, IL-1β) and 63 kDa: anti-inflammatory (TGF-β, IL-10). No Ca2+ ions are required for the interaction with the canonical 29 kDa CLEC10A. Both forms, DBP protein and GcMAF, bind to the 29 kDa CLEC10A. This interaction is characterized by the stochastic mRNA synthesis of the analyzed cytokines. Ex vivo experiments have demonstrated that when there is an excess of GcMAF ligand, CLEC10A forms aggregate, and the mRNA synthesis of analyzed cytokines is inhibited.

A schematic diagram of the presumable mechanism of interaction between the CLEC10A derivatives and GcMAF is provided. The principles and elements of standardizing the GcMAF preparation are elaborated.

Publication and source details

Original title: The Molecular Aspects of Functional Activity of Macrophage-Activating Factor GcMAF

Svetlana S. Kirikovich; Evgeniy V. Levites; Anastasia S. Proskurina; Genrikh S. Ritter; Sergey E. Peltek; Asya R. Vasilieva; Vera S. Ruzanova; Evgeniya V. Dolgova; Sofya G. Oshihmina; Alexandr V. Sysoev; Danil I. Koleno; Elena D. Danilenko; Oleg S. Taranov; Alexandr A. Ostanin; Elena R. Chernykh; Nikolay A. Kolchanov; Sergey S. Bogachev

International Journal of Molecular Sciences · 2023

* Correspondence: svetak@bionet.nsc.ru (S.S.K.); labmolbiol@mail.ru (S.S.B.); Tel.: +7-(383)-363-49-63 (ext. 3411) (S.S.K.)
†

These authors contributed equally to this work.

© 2023 by the authors.2023https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).Russian Ministry of Science and High EducationInstitute of Cytology and Genetics SB RASFWNR-2022-0016Kurchatov Genomic Centre of the Institute of Cytology and Genetics SB RASLLC “ACTIVATOR MAF”LLC “BA-pharma”LLC “KARANAHAN”LLC “S. LAB DIAGNOSTIC”075-15-2019-1662This work was supported by the Russian Ministry of Science and High Education via the Institute of Cytology and Genetics SB RAS (State Budget Project No. FWNR-2022-0016), the Kurchatov Genomic Centre of the Institute of Cytology and Genetics SB RAS (No. 075-15-2019-1662), as well as by LLC “ACTIVATOR MAF”, LLC “BA-pharma”, LLC “KARANAHAN”, and LLC “S. LAB DIAGNOSTIC”.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T05:37:29.871747+00:00

DOI: 10.3390/ijms242417396 · PMC10743851